Hayashi A, Kyuma Y
Kanagawa Cancer Center, Dept. of Neurosurgery.
Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1461-6.
Intra-arterial high dose methotrexate (MTX) infusion therapy for ACNU resistant recurrent gliomas was reported. MTX was administered 16 times to 6 patients. In all cases, 20% mannitol was infused to produce a reversible osmotic blood brain barrier disruption. Dosage of infused MTX was 1,000-2,000 mg per an artery. One case revealed a complete response on CT. Another case showed an intratumoral necrosis. Intra-arterial high dose MTX infusion yielded high arterial and cerebrospinal fluid concentration of MTX. No critical complications were experienced. Dosage of MTX, an interval between the therapies and proper timing to start leucovorin rescue will be discussed.
有报道称采用动脉内高剂量甲氨蝶呤(MTX)输注疗法治疗对ACNU耐药的复发性胶质瘤。6例患者接受了16次MTX治疗。所有病例均输注20%甘露醇以造成可逆性渗透性血脑屏障破坏。每条动脉输注MTX的剂量为1000 - 2000毫克。1例CT显示完全缓解。另1例出现肿瘤内坏死。动脉内高剂量MTX输注使MTX在动脉和脑脊液中达到高浓度。未出现严重并发症。还将讨论MTX的剂量、治疗间隔以及开始亚叶酸解救的合适时机。